www.fdanews.com/articles/115434-cydex-presents-trial-results-for-combination-solution-nasal-spray

CyDex Presents Trial Results for Combination Solution Nasal Spray

March 16, 2009

CyDex Pharmaceuticals, Inc. announced the presentation of Phase 2 clinical trial results of its novel, proprietary Captisol-Enabled budesonide/azelastine nasal spray (CDX-313) for seasonal allergic rhinitis (SAR).
TradingMarkets